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Abstract
Background: In January 2011, human cases with hemorrhagic manifestations in the hospital staff were reported from a
tertiary care hospital in Ahmadabad, India. This paper reports a detailed epidemiological investigation of nosocomial
outbreak from the affected area of Ahmadabad, Gujarat, India.
Principal Findings: Samples from 3 suspected cases, 83 contacts, Hyalomma ticks and livestock were screened for Crimean-
Congo hemorrhagic fever (CCHF) virus by qRT-PCR of which samples of two medical professionals (case C and E) and the
husband of the index case (case D) were positive for CCHFV. The sensitivity and specificity of indigenous developed IgM
ELISA to screen CCHFV specific antibodies in human serum was 75.0% and 97.5% respectively as compared to commercial
kit. About 17.0% domestic animals from Kolat, Ahmadabad were positive for IgG antibodies while only two cattle and a goat
showed positivity by qRT-PCR. Surprisingly, 43.0% domestic animals (Buffalo, cattle, sheep and goat) showed IgG antibodies
in the adjoining village Jivanpara but only one of the buffalo was positive for CCHFV. The Hyalomma anatolicum anatolicum
ticks were positive in PCR and virus isolation. CCHFV was isolated from the blood sample of case C, E in Vero E-6 cells and
Swiss albino mice. In partial nucleocapsid gene phylogeny from CCHFV positive human samples of the years 2010 and 2011,
livestock and ticks showed this virus was similar to Tajikistan (strain TAJ/H08966), which belongs in the Asian/middle east
genetic lineage IV.
Conclusions: The likely source of CCHFV was identified as virus infected Hyalomma ticks and livestock at the rural village
residence of the primary case (case A). In addition, retrospective sample analysis revealed the existence of CCHFV in Gujarat
and Rajasthan states before this outbreak. An indigenous developed IgM ELISA kit will be of great use for screening this
virus in India.
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Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a severe acute
febrile illness caused by the CCHF virus (CCHFV, family
Bunyaviridae, genus Nairovirus), with overall case fatality of 9–50%
[1]. CCHF was first recognized in the Crimean peninsula in the
mid-1940s, [2], but the virus was first isolated from a patient in
Kisangani, Democratic Republic of Congo, in 1956 [3]. Person-
to-person transmission of CCHFV occurs through direct exposure
to blood or other secretions, and instances of nosocomial
transmission are well-documented [1]. The virus is maintained
in nature predominantly in the Ixodid tick vectors, particularly ticks
of the genus Hyalomma [4,5]. CCHFV can persist in the tick
throughout its life stages by transtadial transmission, and can be
passed onto the offspring by transovarial transmission [5]. Among
domestic animals, cattle, sheep, and goat play an important role in
the natural cycle of the virus [6]. In these animals, CCHFV
replicates to high titres in the lung, liver, spleen, and reticuloen-
dothelial system in other organs [7], but generally causes only
subclinical disease. In contrast, human infections often result in
severe hemorrhagic fever (HF), with high levels of viral replication
occurring in all major organs, including the liver [8].
In recent years, a number of zoonotic viral diseases have
emerged in Southeast Asia as Nipah virus, and CCHFV
[9,10,11,12]. CCHF was recently confirmed for the first time in
India, although the virus had been identified nearby in Pakistan
and western China [11,12]. In January 2011, human cases with
hemorrhagic manifestations in the hospital staff were reported
from a tertiary care hospital in Ahmadabad, Gujarat. The clinical
samples of three hospitalized patients were referred to National
Institute of Virology (NIV), Pune and laboratory investigations
confirmed as CCHFV [13]. Here, we report detection and
isolation of CCHFV associated with that nosocomial outbreak in
Gujarat, India, and the presence of the virus in livestock and ticks
www.plosntds.org 1 May 2012 | Volume 6 | Issue 5 | e1653in this region. The disease is newly recognized in India. It is
required to create awareness about this disease in public health
workers and physicians. CCHFV symptoms are difficult to
distinguish not only from other HF, but that the real challenge
is to distinguish the signs and symptoms from other, more
common, febrile diseases.
Materials and Methods
Ethics Statement
NIV, Pune is responsible for investigation of viral disease
outbreaks of human including Zoonosis in India. As per the
mandate of our institute, collection of the clinical samples from
different species of animals for viral isolation and detection is
required. This institute has policy to take approval on the projects
which involves animals from the national committee called
‘‘Committee for the Purpose of Control & Supervision of
Experiments on Animals (CPCSEA) under the Ministry of
Environment and Forests, Government of India. Our study
project No. HCL01/NIV15/2010 is approved by the Institutional
Animal Ethical Committee (IAEC) permitting the use of infant
and adult mice as laboratory animals for isolation of virus and
development of antibodies respectively.
The present nosocomial CCHF outbreak was informed to
Institutional Human Ethical Committee, NIV Pune. As per policy
of institute the work conducted during epidemic situations is
exempt from prior approval from the IEC. Due to this policy, this
study was not pre-approved, but the Committee was notified after
the outbreak. All study participants provided informed consent.
Informed consent was in written format, both in English and local
language (Guajarati). All the record analyzed was anonymized.
Every sample was registered in the central registry of the institute
and allotted a NIV number, which was used throughout the study.
Study area. Ahmadabad is a metropolitan city in Gujarat
state, which shares international boundary with Pakistan. This
communication reports confirmation of a focal nosocomial
outbreak of CCHFV in a tertiary care hospital and finding of
serosurvey in human and animals, RT-PCR and virus isolations
from ticks, livestock and human.
Identification of CCHF nosocomial outbreak and clinical
sample collection
After the request from the Gujarat Government Public Health
authorities, a team from the NIV, Pune visited the private tertiary
care hospital in Ahmadabad, along with local public health
authorities. Medical records of hospitalised patients presented with
HF manifestations were examined, and their family members or
caretakers were interviewed. Blood and urine samples were
collected from cases with HF manifestations and their contacts.
All clinical samples were transported in cold chain to NIV, Pune.
To ascertain whether additional CCHFV infections had occurred
in contacts (hospital staff or family members) lacking CCHF
infection symptoms, an additional 86 blood samples including
CCHF suspected cases were tested by Vector-Best and indige-
nously developed ELISA for detection of IgM antibodies against
CCHFV.
Identification of past CCHF cases in this region
Earlier, there were two serum samples referred to NIV, Pune
from Rajkot, Gujarat, from patients suspected for Hantaan and
Nipah virus in the month of February 2010. These samples were
from the patient and consulting physician. Both had succumbed to
the unknown infection. These samples were also included in the
present study.
Sample collection from rodents, domestic animals and
ticks
Blood samples and ticks were collected from the buffalo, cattle,
sheep and goat from the vicinity of the index case (case A), as well
as from Kolat and surrounding villages, Jivanpura, Navapura and
Changodar. A total of 138 ticks were collected from domestic
animals from Kolat, were classified and pooled as per species.
Eight tick pools were made and homogenized in MEM media.
Tick homogenates were suspended in lysis buffer for viral RNA
extraction. These were tested for CCHFV by qRT-PCR and
nested RT-PCR. Hyalomma tick homogenates were also used for
virus isolation in Vero E-6 cells and Swiss albino mice.
Rodents (n=90) were also trapped from Kolat villege,
morphologically identified and only blood samples from these
animals were collected and transported to NIV, Pune.
Detection of CCHFV by qRT-PCR, nested RT-PCR and virus
isolation
RNA was extracted from human (serum and urine), and animal
serum samples using Qiagen (Valencia, CA, USA) RNA extraction
kit. Tick pools were homogenized in Minutesimum Essential
Medium (MEM). This homogenate was used for RNA extraction
and for virus isolation. In the initial screening CCHFV-specific
TaqMan based qRT-PCR was carried out on the RNA as
previously described [14]. RT-PCR was performed with the
SuperScript One-Step RT-PCR kit with Platinum Taq (Invitrogen
Corp., Carlsbad, CA, USA). Two sets of primers were used for
initial RT-PCR. The primer set CCHF-F2 (TGG ACA CCT
TCA CAA ACT C) and CCHF-R3 (GAC AAA TTC CCT GCA
CCA) amplified a 530 nt region of the nucleocapsid (N) gene of
CCHFV, while nested PCR using the primers CCHF-F3 (GAA
TGT GCA TGG GTT AGC TC) and CCHF-R2 (GAC ATC
ACA ATT TCA CCA GG) amplified a 226 nt region [15]. PCR
products were analyzed on 2% agarose gel electrophoresis and
Ethidium bromide straining. Cyclic sequencing was carried out at
PCR condition 96uC - 1 minute, 96uC - 10 sec, 45uC - 5 sec and
60uC - 4 minutes for 25 cycles using ABI Big-Dye 3.1 dye
chemistry (Applied Biosystems, Foster City, CA). These products
Author Summary
A nosocomial outbreak of CCHFV occurred in January
2011, in a tertiary care hospital in Ahmadabad, Gujarat
State in western India. Out of a total five cases reported,
contact transmission occurred to three treating medical
professionals, all of whom succumbed to the disease. The
only survivor was the husband of the index case. These
results highlight the importance of considering CCHFV as a
potential aetiology for Hemorrhagic fever (HF) cases in
India. This also underlines the need for strict barrier
nursing and patient isolation while managing these
patients. During the investigation presence of CCHFV
RNA in Hyalomma anatolicum ticks and livestock were
detected in the village from where the primary case (case
A) was reported. Further retrospective investigation
confirmed two CCHF human cases in Rajkot village
20 kilometres to the west of Ahmadabad in 2010, and
CCHFV presence in the livestock 200 kilometres to the
north in the neighbouring State Rajasthan. This report
shows the presence of CCHFV in human, ticks and animals
in Gujarat, India. The fact of concern is the spread of this
disease from one state to another due to trading of
livestock.
CCHF Nosocomial Outbreak in India
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er’s instructions and sequencing was performed using the ABI
3100 automated DNA sequencer. The sequences obtained were
curated using KODON software for both the reads from both the
ends. The curated sequences were aligned using program Clustal
W and phylogenetic tree was constructed using neighbour joining
algorithm with 500-bootstrap replicates as implemented in Mega v
4.0 software [16].
The tick pools were first tested by qRT-PCR. Homogenates of
CCHFV-positive tick pools were inoculated into Swiss albino mice
via intracerebral and intraperitoneal routes and into Vero E6 cells
for virus isolation. Virus isolation was attempted from the CCHF
positive human blood, serum, and urine samples.
IgM capture ELISA for screening of human samples
Two CCHF IgM ELISA kits were used; a) commercial kit, b)
indigenously developed test for detection of IgM antibodies in the
human serum samples.
a. Commercial kit. A commercial kit (Vector BEST
Company, Vectocrimean-CHF IgM kit, Novosibirsk, Russia) was
used and the protocol followed as per the manufacturer’s
instructions.
b. Indigenously developed test for CCHF IgM
detection. An IgM capture ELISA was developed for serolog-
ical diagnosis of CCHFV infection from patient’s serum. Briefly,
ELISA wells were coated with anti-human IgM antibodies
(dilution 1:100) (Invitrogen AHI0601) in carbonate buffer
(pH 9.2, 0.025 Molar) overnight at 4uC. These wells were blocked
with 2% skimmed milk powder in 10 mM PBS pH 6.8. Coated
and blocked wells were added with 100 ul of 1:100 diluted serum
samples and incubated at 37uC for one hr. b-Propiolactone (BPL)
inactivated CCHFV infected Vero cell lysate antigen (1:20 diluted,
100 ml/well) was added as a positive antigen, normal Vero cell
lysate was used as negative antigen and incubated for one hr at
37uC. These wells were washed and anti CCHFV antibody raised
in mice (1:4000 diluted, 100 ml/well) was added further incubated
one hr at 37uC. For Anti mouse HRP conjugate (1:4000 diluted,
100 ml) (Pierce Cat No 31446) was added and incubated for one hr
at 37uC. ABTS substrate was added and incubated for 25 minutes.
The reaction was stopped by adding 1% SDS and plates were read
at 414 nm. The plates were washed five times using 10 mM PBS
pH 7.4 with 0.1% Tween-20 (Sigma, USA) at the end of each step.
Appropriate controls were included in the test. CCHFV inactiva-
tion treatment was done in BSL 3 lab, and following inactivation,
the sample was handled in BSL 2 laboratory for ELISA testing.
IgG capture ELISA for screening of animal samples
The inactivated animal serum samples were tested for evidence
of anti-CCHFV IgG using an ELISA kit provided by CDC,
Atlanta. The protocol followed was, ELISA plates were coated
with anti-CCHFV hyper immune mouse ascetic fluid (HMAF)
(dilution 1:1000) in phosphate buffer saline pH 7.4 overnight at
4uC. BPL inactivated CCHFV infected Vero E6 cell lysate antigen
(1:20 diluted, 100 ml/well) was added as a positive antigen, normal
Vero E6 cell lysate was used as negative antigen and incubated for
one hr at 37uC. One hundred ml of 1:100 diluted serum samples
were added and incubated for one hr at 37uC. These wells were
washed and anti-sheep IgG HRP conjugate (1:4000 diluted,
100 ml) was added and incubated for one hr at 37uC. ABTS
substrate was added and incubated at 37uC for 30 minutes. The
reaction was stopped by adding 1% SDS and plates were read at
414 nm. The plates were washed five times using 10 mM PBS
pH 7.4 with 0.1% Tween-20 (Sigma, USA) at the end of each step.
Appropriate controls were included in the test. During investiga-
tion, ELISA was also performed to detect CCHFV specific IgG
antibodies in the animals from the residential area and surround-
ing villages of index case (case A).
Results
Identification of CCHF nosocomial outbreak
In December 2010 and January 2011, a cluster of viral
hemorrhagic fever (VHF) cases was identified in Ahmadabad,
Gujarat, India, which was declared as a nosocomial outbreak of
Crimean-Congo hemorrhagic fever [13]. The initial case identified
was a 25 year old nurse (case C) who worked in a hospital in
Ahmadabad, and presented on January 13th, 2011 with a three
days history of an acute febrile illness characterized by fever, chills,
vomiting and headache followed by hemorrhagic symptoms [13].
Her condition rapidly deteriorated with onset of delirium, multiple
hemorrhagic symptoms (palatal petechia, coughing up of blood,
bleeding from lips, vaginal bleeding, hematuria, hematemesis, and
pulmonary hemorrhage). She was placed in isolation on January
16th and given oral ribavirin based on suspicion of VHF. Despite
treatment, she died on January 18th from multi-organ failure and
disseminated intravascular coagulation (Table 1). Based on the
suspicion of VHF, CCHFV was added to the diagnostic testing
and the patient sera tested positive by qRT-PCR and RT-PCR in
urine and serum [13].
Epidemiologic investigation revealed that case C had earlier
provided care to a patient (case A) with similar VHF symptoms.
Probable case A was a 32 year old housewife from Kolat village,
approximately20 km outside Ahmadabad. She had been admitted to
the hospital on December 27
th, 2010 and had died on December 31st
with VHF-like symptoms (Table 1). While no specimens remained
fromcase Ato allow confirmatorytesting forthepresence ofevidence
of CCHF infection, case A was strongly suspected to be the source of
nosocomial infection of the attending nurse (case C) given the
similarity in clinical and laboratory findings (Table 2). Further
investigation revealed a similar VHF-like illness in a 42 year old
physician (probable case B), who had treated probable case A and
had subsequently presented with symptoms on January 6th 2011
(Table 1) and died on January 13th. Virus transmission to two further
contacts was documented. The husband (case D) of probable
probable case A was admitted to the hospital on January 16th,
displayed similarVHF-like symptoms,wastreated withoral ribavirin,
and recovered and was released on January 26th. Laboratory testing
confirmed evidence of CCHF virus infection. The last identified case
was a 25 year old doctor (case E) who had contact in the hospital with
probable case B and case D. Given his onset of illness on January
26th, case E was likely exposed to case D, who had been admitted on
January 16th and released on the 26th (and case B had died on
January 13th). Despite oral ribavirin treatment, case E progressed to
multi-organ failure and died on January 31st [13].
In total, 3/5 of these hospitalized individuals were confirmed by
qRT-PCR, nested RT-PCR & IgM ELISA as having been infected
with CCHFV. The patients initially reported fever, headache,
myalgia and vomiting. Death occurred within 5–9 days POD in 4 of
the 5 patients. Analysis showed that all the probable cases presented
with similar laboratory data as laboratory confirmed CCHF cases,
including leukopenia, thrombocytopenia, increased SGOT and
SGPT and serum LDH, and increased ferritin and prothrombin
time (Table 2). None of blood samples were found positive by qRT-
PCR from the family and hospital contacts.
Identification of past CCHF cases in this region
With the finding of CCHFV associated with acute hemorrhagic
diseases in Gujarat, retrospective analysis was carried out on some
CCHF Nosocomial Outbreak in India
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similar case descriptions and laboratory findings as reported here
for these Ahmadabad cases. Acute blood samples from two
patients from Rajkot, a town approximately 200 km west of
Ahmadabad, were found positive for CCHFV by qRT-PCR and
RT-PCR, retrospectively confirming them to be CCHF cases.
Detection of CCHFV specific IgM antibodies in human
samples
Out of 86 samples one hospital and one family contact (both
asymptomatic) was positive for presence of IgM antibodies against
CCHFV. Case C and E had a very high titter of IgM in the serum
samples while case D was negative in the early sample which was
positive for qRT-PCR. The 2nd sample of case D was positive for
CCHFV specific IgM and also qRT-PCR. The indigenously
developed ELISA was compared with commercial Vector-Best
assay. The sensitivity and specificity of indigenous ELISA was
75.0% and 97.5% respectively using Vector-Best assay as gold
standard (Table 3). The serum samples of case C, D, and E were
found positive for IgM antibodies while screening with both the
kits. As positive samples were only four, further standardization of
indigenously developed assay using more human serum samples is
required.
Virus isolation from CCHFV positive human samples
The blood and urine samples collected from the laboratory
confirmed CCHF cases (case C, D and E) were inoculated into
Vero E6 cells and Swiss albino mice [intra cerebral. and intra
Table 1. Case descriptions and characteristics of CCHF cases treated in tertiary care hospital at Ahmadabad.
Variable probable case A probable case B case C case D* case E
Occupation Housewife Physician Nurse Farmer Physician
Age [Years] 32 35 25 32 25
Gender Female Male Female Male Male
Date of onset of
illness
December 27, 2010 January 6. 2011 January 10. 2011 January 14. 2011 January 26. 2011
Case descriptions 1 POD: Moderate
fever, joint pain,
headache, tachycardia,
and myalgia received
symptomatic
treatment.
3 POD: Severe
vomiting, epigastric
pain, distended
abdomen, and
admitted to a
tertiary care hospital.
5 POD: Altered
sensorium and ascitis
and admitted to a
medical intensive
care unit, treated
conservatively with
IV fluids, antacids,
antibiotics, antiemetics,
and other supportive
treatment.
7 POD: Oliguria,
anaemic, breathlessness,
acute liver failure. Died,
cardio respiratory arrest
and multi-organ failure.
1 POD: High grade fever
and watery diarrhoea
2 POD: vomiting, severe
headaches, and delirium
4 POD: high grade fever
with delirium and altered
sensorium, admitted to
a private hospital.
5 POD: Eye suffusion and
hematoma on right
inguinal region and thigh
6 POD: Condition
worsened, referred to
another private hospital
7 POD: Suddenly went into
cardiac arrest and died
1 POD: High-grade fever
with chills, vomiting,
and headache
3 POD: Haemoptysis,
bleeding from the lips,
hematuria, palatal
petechiae, hematemesis
6 POD: breathlessness
7 POD: Drowsy and
disoriented and mild
ascitis, melena, vaginal
bleeding, and plural
effusion, pulmonary
hemorrhage. Moderate
hepatomegaly with diffuse
hypoechoic parenchymal
echotexture, and a
contracted gall bladder
with diffuse edematous wall.
8 POD: Died from multi-organ
failure and disseminated
intravascular coagulation.
1 POD: High fever
with chills, vomiting
2 POD: joint pain, epigastric
pain with tenderness and
severe weakness
3 POD: Admitted to same
tertiary care hospital, given
Ribavirin and other
supportive medication
10 POD: recovered and
discharged on January 27,
2011.
1 POD: High grade fever
with rigors, severe
headache, vomiting
2 POD: Severe weakness
4 POD: Mild abdominal
pain, signs of
dehydration, tachycardia
5 POD: Abdominal
distension and tenderness,
sevear haemetemesis,
splenomegaly.
6 POD: Gestrointestinal
bleeding and tachypnoea,
resulted death.
Incubation
period [Probable]
Uncertain 7 9 12 Uncertain
Most likely
exposure
Ticks or livestock
at residence
Percutaneous/direct contact
from body secretion of
probable Case A
Percutaneous/direct contact
from body secretion of
probable Case A
Percutaneous/direct contact
from body secretion of
probable Case A
Case B & D contact; timing
of disease onset suggests
Case D as likely exposure
source
Ribavirin therapy
within 4 days of
onset of
symptoms
No No No Yes Yes
Diagnosis Probable CCHF as
husband [Case D]
confirmed CCHF
Probable CCHF as contact
with probable case A
Laboratory confirmed
CCHF
Laboratory confirmed CCHF Laboratory confirmed
CCHF
Outcome & date Death [3-Jan-11] Death [13-Jan-11] Death [18-Jan-11] Recovered [27-Jan-11] Death [31-Jan-11]
*=Husband of index case.
NB: Clinical laboratory data are mentioned in the Table 2.
doi:10.1371/journal.pntd.0001653.t001
CCHF Nosocomial Outbreak in India
www.plosntds.org 4 May 2012 | Volume 6 | Issue 5 | e1653peritonial. routes]. Sickness and death was observed in mice on 9
th
post infection day (PID). Cytopathic effect was observed in Vero E 6
cells at 3
rd PID and virus was harvested on 7
th PID. CCHFV was
isolated from the blood samples in both mice and Vero E6 cells and
sequence analysis confirmed that the PCR products were derived
from CCHFV RNA. No virus isolate was obtained from the urine
samples; the Ct values (34) of the qRT-PCR also suggested low
viral titres in the urine.
CCHFV circulation and detection of IgG antibodies in
livestock
The initial virus source for this person to person chain of
transmission appeared to be probable case A. She and her
husband (case D) were reside in the rural village of Kolat, made a
living by farming and have daily exposure to livestock and
potentially ticks on these animals (Figure 1). In November and
December 2010, just prior to this outbreak, a serosurvey was
performed to examine livestock for evidence of CCHFV using
blood samples collected from slaughterhouses in the northern
adjoining state of Rajasthan and some more distant areas from
Maharashtra and West Bengal states. The serum samples from
buffalo, goat and sheep from Sirohi district, in southern
Rajasthan were positive for IgG antibodies against CCHFV.
Serum samples from northern West Bengal or Pune area of
Maharashtra were negative (Table 4). The area from which
positivity was reported was approximately 200 kilometres north
of Ahmadabad (Figure 1).
Evidence of CCHFV infection (IgG positive) was also found in a
follow-up study of livestock [including buffalo, cattle, goat, and
sheep] from Kolat (residence of case ‘‘A’’ and case ‘‘D’’) and the
surrounding villages of Changodar, Jivanpara and Navapura
(Table 5). Overall IgG antibodies positivity in the small sample
sizes varied between villages, (10–43%) (Table 5). qRT-PCR
analysis showed evidence of CCHFV infection in the blood
samples from three animals [two cattle and a goat] indicating
circulation of the virus in these animal populations (data not
shown) which was further confirmed by CCHFV specific nested
RT-PCR.
Rodent samples from Rattus rattus rufescens (72), Suncus murinus (6),
Mus booduga (3), Mus musculus (8) and Rattus norvegicus (1) were tested
by qRT-PCR for detection of CCHFV. All the 90 blood samples
were negative for the presence CCHFV.
CCHF virus circulation and detection in Hyalomma ticks
Out of eight tick pools collected from the livestock around the
Kolat village two pools, both Hyalomma anatolicum were positive by
qRT-PCR and RT-PCR specific to CCHFV (Table 6). These two
Hyalomma tick pools also showed CPE in Vero E-6 cells and
propagated in Swiss albino mice also.
Phylogenetic analysis
CCHFV specific nested RT-PCR products were generated from
the blood samples from CCHF cases C, D and E of this outbreak
and two retrospective serum samples of year 2010. Along with this,
sequences of CCHFV positive two tick pools, and four livestock
samples collected in Kolat village were also included for the
analysis. Sequencing analysis of the PCR products generated a
226 nt partial fragment of the virus S gene. Comparison of this
virus sequence fragment with that of other CCHFVs showed that
the strain detected in Ahmadabad had maximum nucleotide
identity (98.0%) with Tajikistan strain (TAJ/H08966) of CCHFV
Table 2. Laboratory data on biochemical and microbiological parameters in suspected CCHF cases during admission to hospital.
Test Unit/Reference Case A (Index case) Case B Case C Case D Case E
WBCs 4000–10,000/CMM 3500 5310 3120 3000 5860
Platelet Count 150000–500000/CMM 5000 59100 50200 104000 27900
Lymphocytes 20–45% 17 11 22 10 12
Ferritin serum 10–291 ng/ml ND 143729 40000 3866 ND
Alanine transaminase [SGPT] 9–52 U/L 2186 453 734 258 165
Blood Urea 14–36 mg/dl 63 37 ND 32 85
Serum LDH 313–618 U/L 23349 1 491 1921 3746
Serum Creatine phosphokinase [Total] 38–174 U/L 45 928 297 333 1027
Aspartate transaminase [SGOT] 14–36 U/L ND 334 ND 195 463
Serum Bilirubin (Total) 0.2–1.3 mg/dl 1.5 0.75 1.98 3.29 2.5
Serum Bilirubin (Direct) 0–0.3 mg/dl 1.3 0.1 1.26 1.55 0.36
Serum Bilirubin (Indirect) 0–1.1 mg/dl ND 0.6 0.72 1.23 1.8
Serum Alkaline Phosphatase 38–120 ND 257 ND 173 ND
Fibrinogen 180–350 mg/dl 80 80 376 ND 1.6
Prothrombin Time Test 11–16 Sec 34 28 25 25 20
*ND : Not Done.
doi:10.1371/journal.pntd.0001653.t002
Table 3. Comparison of indigenously developed and
commercial IgM capture ELISA for detection of antibodies.
Result by NIV kit Result by Commercial kit Total
Positive Negative
Positive 3 2 5
Negative 1 80 81
Total 4 82 86
Note: 262 table for comparison of sensitivity and specificity of NIV and Vector-
Best ELISA tests (Sensitivity=3/4=75.0%; Specificity=80/82=97.5%).
doi:10.1371/journal.pntd.0001653.t003
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(Figure 2).
Discussion
India did not report any CCHF cases until January 2011 [13].
However, the presence of CCHFV in India had been suspected,
since it was detected in the neighbouring countries of Pakistan and
western China, especially once CCHFV was first isolated from the
tick species Hyalomma anatolicum and from a mixture of Hyalomma
and Boophilus tick species collected in Pakistan [17,18]. In the past
a serosurvey was conducted in Jammu and Kashmir, the western
border districts of India (1976), showed CCHFV antibodies in
many of the animal sera, however, studies by Rodrigues et. al.,
(1986) precipitated the antibody in 34 of the 655 domestic animal
sera from different states/territories of southern India, and from
Maharashtra state. Most of the positive sera were collected from
goat in southern India [19].
CCHFV IgG antibodies were detected in animals in November
and December 2010, in the neighbouring Rajasthan state in
buffalo, cattle, goat, and sheep. The border between India and
Pakistan is porous for the entry of livestock animals, which might
play an important role in transmission of CCHFV between these
countries. Our investigation identified CCHFV in cattle, goat, and
buffalo from surrounding villages also. These villages have a large
buffalo population. Since this virus is isolated from the ticks
collected from buffalo in the affected area, these animals may have
an important role in infecting large number of ticks in these areas.
Figure 1. CCHF positive human cases and IgG antibody positive animals from Gujarat and Rajasthan state.
doi:10.1371/journal.pntd.0001653.g001
Table 4. Cross-sectional survey of anti-CCHFV IgG in animals
from three Indian states (November–December, 2010).
Animal
Number
tested
Number positive
for CCHFV IgG
Pune area, Maharashtra
Buffalo 31 00
Goat 68 00
Pig 25 00
Sheep 08 00
Total (a) 132 00
North West Bengal
Cattle 05 00
Goat 68 00
Total (b) 73 00
Sirohi district, Rajasthan
Buffalo 15 01
Goat 10 03
Sheep 09 06
Total (c) 34 10 (29.4%)
Total (a+b+c) 239 10 (4.1%)
doi:10.1371/journal.pntd.0001653.t004
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CCHFV, suggesting that this disease is not due to recent
introduction of CCHFV to this area. The virus strain studied
here showed highest homology (98–100.0%) with the Tajikistan
strain (TAJ/H08966), suggesting Asian/middle east origin (IV
clade).
Among the CCHF confirmed cases, serum ferritin levels were
high; in the fatal cases, such high ferritin levels have also been
reported as indicator of severity of the disease [20]. Leukopenia,
thrombocytopenia, increased SGOT, SGPT, LDH, and increased
prothrombin time was in accordance to the World Health
Organization (WHO) case definition of CCHF. The increased
serum creatine phosphokinase is perhaps indicative of severe
damage to the liver and other organs. Swiss albino mice inoculated
with patient serum also showed intra-abdominal bleeding,
multifocal lung necrosis, liver enlargement, and necrosis. Interest-
ingly, blood smear examination reports from all patients showed
erythophagocytosis, and investigations of mice inoculated with
patient blood samples revealed similar findings. Case-D, who
recovered 10 post onset days (POD) and was monitored for the
presence of virus in the urine, and found positive for CCHF up to
13 days POD. This raises the question whether a recovered patient
discharged before 13–14 days POD can still be a potential source
of infection.
The short incubation period and many of the nonspecific
symptoms of CCHF, which overlap with the symptoms of other
hemorrhagic fevers, raise the risk for misdiagnosis and person-to-
person transmission of CCHFV. This puts close contacts, and
healthcare providers at risk for secondary infection. The symp-
toms, signs, and laboratory abnormalities of CCHF are nonspe-
cific and can overlap with those of other tropical infections
(dengue, Kyasanur Forest disease and leptospirosis). The efficacy
of ribavirin is still debated, and it is difficult to say whether the only
surviving CCHF case (husband of index case) in the present study
was due to immediate ribavirin oral therapy. These features
highlight the importance of quick diagnosis of the etiologic agent
associated with HF cases. Moreover, once CCHF is suspected,
patients and specimens should be handled with adequate biosafety
measures. Authorities and contacts should be immediately
notified, and patients’ samples should be sent for specific
laboratory diagnosis, keeping in view the precautions associated
with BSL 4 risk group agent hazards.
Nosocomial transmission in this outbreak as reported here and
earlier by Mishra et. al., (2011) is evident by the development of
disease in close contacts of a CCHF patient [13]. This episode of
nosocomial infection resulted in four deaths in a small population
as of February 15, 2011. There are very few commercially
available kits for detection of CCHFV antibodies from humans.
Therefore, an attempt was made to develop indigenous assays for
detection of CCHFV antibodies. The performance of indigenous
assay was satisfactory as compared to commercially available
Vector-Best assay. Since, the positive samples were only four,
further standardization of indigenously developed assay using
more human serum samples is required. Detection of IgM
antibodies in one each hospital and family contacts suggest a
low level of asymptomatic cases. The CCHF positivity of the two
retrospective human samples from Rajkot, Gujarat also indicate
that disease was prevalent in this state for a long time and probably
might have contributed significant morbidity and mortality in the
past in this state.
Table 5. Anti-CCHFV IgG antibody positivity in animals from
four villages in Ahmadabad.
Village Animal Total tested IgG positive Percent positivity
Changodar Buffalo 15 2
Cattle 8 1
Goat 36 3
Sheep 1 0
Total 60 6 10.00
Jivanpara Buffalo 9 2
Cattle 10 1
Goat 20 11
Sheep 30 16
Total 69 30 43.48
Kolat Buffalo 75 16
Cattle 52 1
Goat 20 9
Sheep 1 0
Total 148 26 17.57
Navapura Buffalo 24 4
Cattle 4 0
Total 28 4 14.29
Grand Total 305 66 21.6
doi:10.1371/journal.pntd.0001653.t005
Table 6. CCHFV detection in ticks from Kolat village, Sanand Taluka, Ahmadabad, Gujarat.
Pool # qRT-PCR Tick species [host] Tick sex [n]
1 Negative Hyalomma anatolicum [Buffalo] Female [19]
2 Positive H. anatolicum anatolicum [Buffalo] Male [31]
3 Negative H. anatolicum anatolicum [Buffalo] Nymph [10], Females [5]
4 Negative H. anatolicum anatolicum [Buffalo] Male [20], Female [4]
5 Positive H. anatolicum anatolicum [Buffalo] Male [13], Female [1]
6 Negative Ornithodoros savygni [Cattle shed soil] Nymph [23]
7 Negative O. savygni [Cattle shed soil] Male [10]
8 Negative O. savygni [Cattle shed soil] Female [2]
Grand Total 138
doi:10.1371/journal.pntd.0001653.t006
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